In pediatric acute myeloid leukemia (AML), cytogenetic abnormalities are strong indicators of
prognosis. Some recurrent cytogenetic abnormalities, such as t (8; 16)(p11; p13), are so rare …

In pediatric acute myeloid leukemia (AML), cytogenetic abnormalities are strong indicators of
prognosis. Some recurrent cytogenetic abnormalities, such as t (8; 16)(p11; p13), are so rare …

Abstract Abstract 2516 Introduction: In pediatric acute myeloid leukemia (AML) cytogenetic
abnormalities are important for prognosis and treatment stratification. Some recurring …

Background: Despite the confirmed favorable prognosis of childhood t (8; 21) acute myeloid
leukemia (AML), recent reports suggest heterogeneity in survival outcomes in this subtype of …

Objective Compared with other cytogenetic acute myeloid leukemia (AML) groups, patients
with core-binding factor AML (CBF-AML) are considered as a favorable AML risk group …

We read with considerable interest the recent report by Rubnitz et al, 1 regarding the
occurrence of t (9; 11)(p22; q23) as the most favorable genetic factor for children with acute …

PURPOSE: To determine the impact of MLL rearrangements on the outcome of children with
acute myeloid leukemia (AML). PATIENTS AND METHODS: We analyzed the clinical and …

Acute myeloid leukemia (AML) patients with t (8; 16)(p11. 2; p13) constitute a small
subgroup with a distinct genetic and clinical profile. We present a unique case of a female …

To elucidate the clinical and biological features of childhood acute myeloid leukemia (AML)
with the t (8; 21), we reviewed the records of patients with AML treated at St Jude Children's …

Trisomy 8 (+ 8) is a common cytogenetic aberration in acute myeloid leukemia (AML);
however, the impact of+ 8 in pediatric AML is largely unknown. We retrospectively …